HT
SRPT icon

HAP Trading’s Sarepta Therapeutics SRPT Stock Holding History

HAP Trading’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,000
Closed -$525K – 954
2025
Q2 		$525K Buy
+16,000
New +$683K 0.05% 185
2023
Q2 		– Sell
-51,900
Closed -$60K – 1342
2023
Q1 		$60K Buy
+51,900
New +$6.73M 0.01% 488
2022
Q1 		– Sell
-11,000
Closed -$102K – 2731
2021
Q4 		$102K Sell
11,000
-4,900
-31% -$419K ﹤0.01% 1228
2021
Q3 		$105K Buy
+15,900
New +$1.22M ﹤0.01% 1239
2021
Q2 		– Sell
-17,200
Closed -$208K – 2680
2021
Q1 		$208K Sell
17,200
-4,100
-19% -$378K 0.01% 754
2020
Q4 		$193K Buy
21,300
+9,800
+85% +$1.45M 0.01% 966
2020
Q3 		$125K Sell
11,500
-800
-7% -$122K 0.01% 757
2020
Q2 		$51K Buy
+12,300
New +$1.67M ﹤0.01% 1035
2020
Q1 		– Sell
-22,500
Closed -$54K – 1529
2019
Q4 		$54K Buy
22,500
+11,300
+101% +$1.14M ﹤0.01% 693
2019
Q3 		$243K Sell
11,200
-211,000
-95% -$24.9M 0.02% 452
2019
Q2 		$92K Buy
222,200
+208,500
+1,522% +$25.3M 0.01% 625
2019
Q1 		$123K Buy
13,700
+600
+5% +$77.1K 0.01% 515
2018
Q4 		$181K Sell
13,100
-4,600
-26% -$575K 0.01% 566
2018
Q3 		$74K Sell
17,700
-3,700
-17% -$506K ﹤0.01% 578
2018
Q2 		$352K Buy
+21,400
New +$2.02M 0.02% 375
2017
Q1 		– Sell
-84,100
Closed -$1.17M – 1236
2016
Q4 		$1.17M Sell
84,100
-119,500
-59% -$4.8M 0.06% 230
2016
Q3 		$226K Buy
203,600
+167,100
+458% +$5.05M 0.01% 479
2016
Q2 		$550K Buy
+36,500
New +$676K 0.03% 300
2015
Q3 		– Sell
-510,000
Closed -$1.82M – 1169
2015
Q2 		$1.82M Buy
+510,000
New +$10.4M 0.11% 186
2013
Q3 		– Sell
-288,800
Closed -$840K – 880
2013
Q2 		$840K Buy
+288,800
New +$10.3M 0.03% 400

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

HAP Trading's SRPT Position: Q3 2024 in Review

HAP Trading sold out of Sarepta Therapeutics (SRPT) in Q3 2024, closing a stake of 41,077 shares — an estimated $6.49M sold.

HAP Trading first reported a position in SRPT in Q2 2013 and held it in 9 quarters. The position peaked at $7.67M in Q2 2019. 458 funds tracked by Wall St. Rank hold SRPT as of Q3 2024.

  • HAP Trading reported no remaining Sarepta Therapeutics position as of Q3 2024 after selling out during the quarter.
  • HAP Trading sold 41,077 Sarepta Therapeutics shares in Q3 2024, an estimated $6.49M.
  • HAP Trading first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 9 quarters.
  • HAP Trading's Sarepta Therapeutics position peaked at $7.67M in Q2 2019.
  • 458 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2024.

Based on HAP Trading's 13F filing for Q3 2024, filed 12 Nov 2024.